These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28073513)

  • 21. Brivudin induced delirium: a case report.
    Gonen I; Turan H; Ozdemir D; Sahin A; Sarıtas A
    J Chemother; 2012 Aug; 24(4):229-30. PubMed ID: 23040689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine-induced lichenoid drug eruption: a case report.
    Gehlhausen JR; Strausburg MB; Aouthmany M; Katona TM; Turner MJ
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capecitabine-induced eruptive acral hyperpigmentation: Clinical and dermoscopic evaluation of two cases.
    Peccerillo F; Pampena R; Giannetti L; Pellacani G; Longo C
    Dermatol Ther; 2019 May; 32(3):e12853. PubMed ID: 30748073
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
    Palomera L; Azaceta G; Varo MJ; Soria J; Gutierrez M
    Haematologica; 1998 Nov; 83(11):1045-6. PubMed ID: 9864929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capecitabine Toxicity and Dihydropyrimidine Dehydrogenase Deficiency.
    Tariq Z; Mudge R; Phillips S
    Am J Ther; 2018; 25(6):e742-e743. PubMed ID: 29889674
    [No Abstract]   [Full Text] [Related]  

  • 26. [Delayed elimination of methotrexate after high-dose infusion].
    Kuleva SA
    Vopr Onkol; 2013; 59(1):126-31. PubMed ID: 23814840
    [No Abstract]   [Full Text] [Related]  

  • 27. Capecitabine-induced hyperglycemia without hyperlipidemia: a case report.
    Avishek A; Jayanthi M; Biswajit D
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1519-1521. PubMed ID: 28752256
    [No Abstract]   [Full Text] [Related]  

  • 28. Capecitabine: toxic encephalopathy.
    Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688902
    [No Abstract]   [Full Text] [Related]  

  • 29. Pyogenic granuloma possibly associated with capecitabine therapy.
    Fujiwara C; Motegi SI; Sekiguchi A; Amano H; Ishikawa O
    J Dermatol; 2017 Nov; 44(11):1329-1331. PubMed ID: 27864844
    [No Abstract]   [Full Text] [Related]  

  • 30. Unilateral Capecitabine-related Hand-foot Syndrome.
    Matsuda S; Koketsu H; Hayakawa M; Nagata N
    Intern Med; 2015; 54(21):2779. PubMed ID: 26521911
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of serum folate level with toxicity of capecitabine in patients with colorectal cancers: a prospective cohort study.
    Chan SL; Ma BB; Chan AK
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):29-31. PubMed ID: 29937443
    [No Abstract]   [Full Text] [Related]  

  • 32. [64-year-old patient with efflorescences on the upper and lower legs].
    Borde JP; Offensperger WB
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1737-8. PubMed ID: 20812158
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
    Demir S; Olgac M; Saglam S; Gelincik A; Colakoglu B; Buyukozturk S
    J Investig Allergol Clin Immunol; 2016; 26(1):66-7. PubMed ID: 27012024
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.
    Ambesh P; Zivari K; Obiagwu C; Shetty V; Kamholz S; Hollander G; Shani J
    Br J Clin Pharmacol; 2018 Apr; 84(4):800-802. PubMed ID: 29336052
    [No Abstract]   [Full Text] [Related]  

  • 35. Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil.
    Kodali S; Bathini V; Rava P; Tipirneni E
    J Gastrointest Cancer; 2017 Mar; 48(1):66-69. PubMed ID: 26744322
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.
    Cubiró X; Planas-Ciudad S; Garcia-Muret MP; Puig L
    JAMA Dermatol; 2018 Jan; 154(1):99-100. PubMed ID: 29117285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capecitabine-induced acral and mucosal hyperpigmentation.
    Verma P
    Indian J Dermatol Venereol Leprol; 2017; 83(5):583. PubMed ID: 28656912
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential expression of capecitabine-induced hand foot syndrome on paretic limb.
    Tripathy T; Singh BS; Behera D; Kar BR
    Indian J Dermatol Venereol Leprol; 2018; 84(6):720-722. PubMed ID: 30246703
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent and fatal pancytopenia due to repeated colchicine self administration.
    Demy M; Varache N; Coindre JP; Dernis E; Puéchal X
    Eur J Intern Med; 2009 Sep; 20(5):e116-7. PubMed ID: 19712830
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiotoxicity of capecitabine: Captions not to bin.
    De Gennaro L; Brunetti ND; Resta M; Rutigliano D; Tarantini L; Caldarola P
    Int J Cardiol; 2017 Feb; 229():6. PubMed ID: 27940005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.